Etiology and portal vein thrombosis in Budd-Chiari syndrome

World Journal of Gastroenterology

Volumn 14, Issue 18, 2008, Pages 2858-2862

  Uskudar, Oguz ^a,b   Akdogan, Meral ^a   Sasmaz, Nurgul ^a   Yilmaz, Sevinc ^a   Tola, Muharrem ^a   Sahin, Burhan ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b Hematology Unit ^*  (Turkey)

Author keywords

Behcet's disease; Budd Chiari syndrome; Etiology; Portal thrombosis; Web

Indexed keywords

ACTIVATED PROTEIN C; ALANINE AMINOTRANSFERASE; ALBUMIN; ANTINUCLEAR ANTIBODY; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN; UREA; WARFARIN;

ABDOMINAL BLEEDING; ADOLESCENT; ADULT; AGED; ANTICOAGULATION; ARTICLE; ASCITES; BEHCET DISEASE; BLOOD CHEMISTRY; BONE MARROW EXAMINATION; BRAIN HEMORRHAGE; BUDD CHIARI SYNDROME; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ECHINOCOCCOSIS; ECHOGRAPHY; ESOPHAGUS VARICES; FEMALE; HUMAN; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL EXAMINATION; PORTAL PHLEBOGRAPHY; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; PREGNANCY; PROSPECTIVE STUDY; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN TIME; RISK FACTOR; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TURKEY (REPUBLIC);

EID: 48049108251     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.2858     Document Type: Article

References (19)

1. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004; 350: 578-585
2. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, van Hattum J, Chamuleau RA, Adang RP, Vandenbroucke JP, van Hoek B, Rosendaal FR. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000; 96: 2364-2368
3. Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, Erlinger S, Briere J, Valla D. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31: 587-591
4. Hirshberg B, Shouval D, Fibach E, Friedman G, Ben-Yehuda D. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythernia vera in the Budd-Chiari syndrome. J Hepatol 2000; 32: 574-578
5. Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, Erlinger S, Valla DC. Factor V Leiden related Budd-Chiari syndrome. Gut 2001; 48: 264-268
6. Bismuth E, Hadengue A, Hammel P, Benhamou JP. Hepatic vein thrombosis in Behcet's disease. Hepatology 1990; 11: 969-974
7. Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, Larsson S, Vaidya Y. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 1996; 11: 170-179
8. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from Western India. Hepatology 2001; 34: 666-670
9. Okuda H, Yamagata H, Obata H, Iwata H, Sasaki R, Imai F, Okudaira M, Ohbu M, Okuda K. Epidemiological and clinical features of Budd-Chiari syndrome in Japan. J Hepatol 1995; 22: 1-9
10. Hadengue A, Poliquin M, Vilgrain V, Belghiti J, Degott C, Erlinger S, Benhamou JP. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994; 106: 1042-1047
11. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis 2002; 22: 5-14
12. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology 1998; 28: 1191-1198
13. Victor S, Jayanthi V, Panchanadam M, Chitra S, Vijayalakshmi CS, Madanagopalan N. Budd Chiari syndrome and pericaval filariasis. Trop Gastroenterol 1994; 15: 161-168
14. Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gaken J, Wendon J, Heaton ND, Mufti GJ. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology 2006; 130: 2031-2038
15. Smalberg JH, Murad SD, Braakman E, Valk PJ, Janssen HL, Leebeek FW. Myeloproliferative disease in the pathogenesis and survival of Budd-Chiari syndrome. Haematologica 2006; 91: 1712-1713
16. Plume G, Vaya A, Ferrando F, Mira Y, Orbis F. JAK2V617F mutation as a marker of a latent myeloproliferative disorder in a patient with Budd-Chiari syndrome and factor V Leiden mutation. Thromb Haemost 2007; 98: 681-682
17. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet's disease. Am J Gastroenterol 1997; 92: 858-862
18. Mahmoud AE, Helmy AS, Billingham L, Elias E. Poor prognosis and limited therapeutic options in patients with Budd-Chiari syndrome and portal venous system thrombosis. Eur J Gastroenterol Hepatol 1997; 9: 485-489
19. Murad SD, Valla DC, de Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006; 101: 83-90